Across jurisdictions, pharmaceutical companies are navigating recent changes in patent laws. Finnegan attorneys Sanya Sukduang and Emily R. Gabranski spoke with Asia IP on the ever-increasing complexity of patents in the life sciences field and what constitutes patentable subject matter, particularly in the biotechnology sector.
Award/Ranking
Savoy Magazine Names Mareesa Frederick on its 2024 Most Influential Lawyers List
August 2, 2024
Announcement
Two Finnegan Partners Honored with Women, Influence, and Power in Law Awards
July 31, 2024
Commentary
How I Made Partner: 'Be Reliable and Responsible,' Says Sonja Sahlsten of Finnegan
June 14, 2024
Commentary
World IP Day: EPO Reveals 33% Jump in Cleantech Inventions Over Five Years
April 26, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.